IBM’s first quarter performance in 2025 saw flat year-over-year sales, yet outpaced revenue and profit expectations set by Wall Street. Despite this, shares declined following the release as ...

CoreWeave’s breakout debut this year has dazzled investors, but with valuation concerns now in play, should investors sell ...

Clarius Group LLC gave its IBM investment a healthy protein shake, beefing up its stake by 29.5% with an extra 1,545 shares ...

Nebius stock surges past $12B market cap with strong momentum. The management has forecasted reaching $1 billion in ARR by ...

Rigetti Computing continues to sell far more shares to raise cash than the company actually sells computers, while quantum ...